Patel Mahesh V. Insider Trading Activity

Average Profitability
40.01%
Insider Buys Quantity
16
Insider Buys Sum
$477,749.37
Insider Sells Quantity
4
Insider Sells Sum
$147,952.65

Insider Activity of Patel Mahesh V.

According to the SEC Form 4 filings, Patel Mahesh V., being in a position of

  1. Chief Executive Officer at Lipocine Inc.,
    оver the last 12 months, has bought 50000 shares for $101,250, and sold 0 shares,
    over all time since 2014-11-13, has bought 672706 shares for $578,999, and sold 114000 shares for $147,953.

Biography of Patel Mahesh V.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$101,2502100
Sells
$000

Comparison of Insiders on Amount of Buys and Sells

2026-04-06PurchaseLipocine Inc.
LPCN
Chief Executive Officer
25,000
0.4804%
$2.03$50,750+13.92%
2026-04-02PurchaseLipocine Inc.
LPCN
Chief Executive Officer
25,000
0.1003%
$2.02$50,500+7.8%
2023-05-25PurchaseLipocine Inc.
LPCN
CEO and President
8,706
0.1614%
$5.03$43,791-23.22%
2023-03-24PurchaseLipocine Inc.
LPCN
CEO and President
150,000
0.0107%
$0.32$48,000-21.29%
2023-03-17PurchaseLipocine Inc.
LPCN
CEO and President
50,000
0.0032%
$0.33$16,500-32.85%
2022-11-14PurchaseLipocine Inc.
LPCN
CEO and President
75,000
0.0051%
$0.39$29,250-23.07%
2022-09-27PurchaseLipocine Inc.
LPCN
CEO and President
100,000
0.0069%
$0.41$41,000-19.07%
2022-05-16PurchaseLipocine Inc.
LPCN
CEO and President
50,000
0.0032%
$0.77$38,495-39.61%
2021-11-18PurchaseLipocine Inc.
LPCN
CEO and President
25,000
0.0017%
$1.09$27,250-21.1%
2020-12-16SaleLipocine Inc.
LPCN
Chief Executive Officer
15,000
0.0013%
$1.35$20,250-1.45%
2020-12-04SaleLipocine Inc.
LPCN
Chief Executive Officer
43,500
0.004%
$1.57$68,134-11.04%
2019-12-31PurchaseLipocine Inc.
LPCN
CEO and President
40,000
0.0057%
$0.38$15,340+214.05%
2019-12-10PurchaseLipocine Inc.
LPCN
President and CEO
25,000
0.0036%
$0.40$9,975+143.58%
2019-12-04SaleLipocine Inc.
LPCN
CEO and President
43,500
0.0061%
$0.41$17,835+124.07%
2019-11-26PurchaseLipocine Inc.
LPCN
President and CEO
25,000
0.0036%
$0.43$10,696+112.93%
2019-11-18PurchaseLipocine Inc.
LPCN
CEO and President
50,000
0.0071%
$0.40$20,095+121.63%
2017-12-29SaleLipocine Inc.
LPCN
CEO, President
12,000
0.0036%
$3.48$41,734-59.3%
2015-09-30PurchaseLipocine Inc.
LPCN
President and CEO
8,000
0.0029%
$11.84$94,709-18.51%
2014-11-25PurchaseLipocine Inc.
LPCN
President and CEO
4,000
0.0019%
$5.10$20,400+52.3%
2014-11-24PurchaseLipocine Inc.
LPCN
President and CEO
4,000
0.002%
$5.45$21,800+47.18%
Total: 22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.